The Impacts of Endocrine Disrupterson Wildlife, People and Their Environments — the Weybridge+15 (1996–2011) Report

Total Page:16

File Type:pdf, Size:1020Kb

The Impacts of Endocrine Disrupterson Wildlife, People and Their Environments — the Weybridge+15 (1996–2011) Report EEA Technical report No 2/2012 The impacts of endocrine disrupters on wildlife, people and their environments The Weybridge+15 (1996–2011) report ISSN 1725-2237 EEA Technical report No 2/2012 The impacts of endocrine disrupters on wildlife, people and their environments The Weybridge+15 (1996–2011) report Design: EEA Layout: EEA/Pia Schmidt Cover photo: © istockphoto/Martin Huber Legal notice The contents of this publication do not necessarily reflect the official opinions of the European Commission or other institutions of the European Union. Neither the European Environment Agency nor any person or company acting on behalf of the Agency is responsible for the use that may be made of the information contained in this report. Copyright notice © EEA, Copenhagen, 2012 Reproduction is authorised, provided the source is acknowledged, save where otherwise stated. Information about the European Union is available on the Internet. It can be accessed through the Europa server (www.europa.eu). Luxembourg: Publications Office of the European Union, 2012 ISBN 978-92-9213-307-8 ISSN 1725-2237 doi:10.2800/41462 REG.NO. DK-000244 European Environment Agency Kongens Nytorv 6 1050 Copenhagen K Denmark Tel.: +45 33 36 71 00 Fax: +45 33 36 71 99 Web: eea.europa.eu Enquiries: eea.europa.eu/enquiries Contents Contents Acknowledgements .................................................................................................... 5 Executive summary .................................................................................................... 6 1 General introduction .............................................................................................. 8 1.1 Endocrine disruption and the European Union ....................................................... 8 1.2 Workshop overview and objectives ...................................................................... 8 2 Review summaries .............................................................................................. 10 2.1 Human health effects .......................................................................................10 2.1.1 Introduction ...........................................................................................10 2.1.2 Progress summary ..................................................................................10 2.1.3 Knowledge gaps and research priorities ....................................................13 2.1.4 Implications for risk assessment and regulatory action ��������������������������������13 2.2 Wildlife effects .................................................................................................14 2.2.1 Introduction ...........................................................................................14 2.2.2 Progress summary ..................................................................................14 2.2.3 Knowledge gaps and research priorities .....................................................15 2.2.4 Implications for risk assessment and regulatory action ��������������������������������16 2.3 Mechanisms and laboratory animal models ..........................................................16 2.3.1 Introduction ...........................................................................................16 2.3.2 Progress summary ..................................................................................16 2.3.3 Knowledge gaps and research priorities .....................................................17 2.3.4 Implications for risk assessment and regulatory action ��������������������������������18 2.4 Exposure, risk and policy ..................................................................................18 2.4.1 Introduction ...........................................................................................18 2.4.2 Progress summary ..................................................................................18 2.4.3 Research priorities ..................................................................................20 2.4.4 Implications for risk assessment and regulatory action ��������������������������������21 2.5 Key conclusions, challenges and recommendations ..............................................21 3 Background reviews ............................................................................................ 24 3.1 Human health effects .......................................................................................24 3.1.1 Male relevant endpoints ..........................................................................24 3.1.2 Female relevant endpoints .......................................................................28 3.1.3 Puberty .................................................................................................31 3.1.4 Possible effects on non-reproductive organs �����������������������������������������������33 3.1.5 References ............................................................................................36 The impacts of endocrine disrupters on wildlife, people and their environments 3 Contents 3.2 Wildlife effects .................................................................................................49 3.2.1 Mammals ..............................................................................................49 3.2.2 Fish ......................................................................................................53 3.2.3 Amphibians ...........................................................................................56 3.2.4 Reptiles .................................................................................................58 3.2.5 Birds .....................................................................................................59 3.2.6 Invertebrates .........................................................................................62 3.2.7 References ............................................................................................68 3.3 Mechanisms and laboratory animal models ..........................................................90 3.3.1 Overview of current in vivo animal and in vitro research ������������������������������90 3.3.2 Mechanisms of endocrine disruption ..........................................................91 3.3.3 Mixture effects of EDCs ...........................................................................92 3.3.4 The nervous system: Behavioural studies, neurodevelopment and thyroid effects ........................................................................................94 3.3.5 Low-dose effects of EDCs ........................................................................94 3.3.6 Screening and testing programmes for EDCs ����������������������������������������������95 3.3.7 References ............................................................................................97 3.4 Exposure, risk and policy ................................................................................100 3.4.1 Introduction .........................................................................................100 3.4.2 Issues for exposure assessment, hazard characterisation and risk evaluation .....................................................................................101 3.4.3 Testing, screening and implications for risk assessment and policy 104 3.4.4 References ..........................................................................................107 4 EU-funded research projects of relevance to the report .....................................111 4 The impacts of endocrine disrupters on wildlife, people and their environments Acknowledgements Acknowledgements This report is an updated compilation of papers Mechanisms and laboratory animal models and discussions at the 'Weybridge+10' event in L. Earl Gray, Environmental Protection Agency, 2006, under the auspices of the Finnish Presidency Research Triangle Park, NC, USA; of the European Union, co-organised by the Richard M. Sharpe, MRC Human Reproductive European Commission's Directorate-General for Sciences Unit, Edinburg, the United Kingdom; and Research (now Directorate-General for Research Anna-Maria Vinggaard, Technical University of and Innovation), the Academy of Finland, and the Denmark, Lyngby, Denmark. European Environment Agency. The report was commissioned by the European Exposure, risk and policy Environment Agency in 2009 and the project Andreas Kortenkamp, Brunel University, Middlesex, manager was David Gee with the assistance of the United Kingdom. Gitte Nielsen. Different sections of the background reviews were Dr Rachel Gomes edited the draft together with the written by the following groups of scientists. host of the meeting Jorma Toppari. Since a long time elapsed between the workshop Human health effects and now, the draft report was updated and edited Anna-Maria Andersson, Rigshospitalet, by Professor Susan Jobling, Brunel University Copenhagen, Denmark; London Institute for the Environment, Middlesex, Olle Söder, Astrid Lindgren's Hospital, Karolinska the United Kingdom. Institute, Stockholm, Sweden; and Jorma Toppari, University of Turku, Turku, Finland. Liability statement Wildlife effects This publication reflects only the authors' views. Jörg Oehlmann, Johann Wolfgang Goethe University, Neither the European Commission nor any person Frankfurt am Main, Germany; acting on its behalf may be held responsible for Tom Pottinger, Lancaster Environment Centre, the the use which may be made of the information United Kingdom; and contained
Recommended publications
  • Cryptorchidism and Endocrine Disrupting Chemicals ⇑ Helena E
    Molecular and Cellular Endocrinology 355 (2012) 208–220 Contents lists available at SciVerse ScienceDirect Molecular and Cellular Endocrinology journal homepage: www.elsevier.com/locate/mce Review Cryptorchidism and endocrine disrupting chemicals ⇑ Helena E. Virtanen , Annika Adamsson Department of Physiology, University of Turku, Finland article info abstract Article history: Prospective clinical studies have suggested that the rate of congenital cryptorchidism has increased since Available online 25 November 2011 the 1950s. It has been hypothesized that this may be related to environmental factors. Testicular descent occurs in two phases controlled by Leydig cell-derived hormones insulin-like peptide 3 (INSL3) and tes- Keywords: tosterone. Disorders in fetal androgen production/action or suppression of Insl3 are mechanisms causing Cryptorchidism cryptorchidism in rodents. In humans, prenatal exposure to potent estrogen diethylstilbestrol (DES) has Testis been associated with increased risk of cryptorchidism. In addition, epidemiological studies have sug- Endocrine disrupting chemical gested that exposure to pesticides may also be associated with cryptorchidism. Some case–control stud- ies analyzing environmental chemical levels in maternal breast milk samples have reported associations between cryptorchidism and chemical levels. Furthermore, it has been suggested that exposure levels of some chemicals may be associated with infant reproductive hormone levels. Ó 2011 Elsevier Ireland Ltd. All rights reserved. Contents 1. Background.
    [Show full text]
  • TOXIC EQUIVALENCY FACTORS for DIOXIN-LIKE Pcbs
    Chemosphere, Vol. 28, No. 6, pp. 1049-1067, 1994 Perl~amon ELsevier Science Ltd Printed in Great Britain 0045-6535/94 $6.00+0.00 0045-6535(94)E0070-A TOXIC EQUIVALENCY FACTORS FOR DIOXIN-LIKE PCBs Report on a WHO-ECEH and IPCS consultation, December 1993 Ahlborg UG 1., Becking GC 2, Birnbaum LS 3, Brouwer A 4, Derks HJGM s, Feeley M6, Color G 7, Hanberg A 1, Larsen JC s, Liem AKD s, Safe SH9, Schlatter C 10, Wvern F 1, Younes M 11, Yrj~inheikki E 12 1 Karolinska Institutet, Box 210, S-171 77 Stockholm, Sweden 2IPCS/IRRU, Research Triangle Park, NC, USA; 3USEPA, Research Triangle Park, NC, USA; 4Agricultural University, Wageningen, The Netherlands; 5Nan Inst Publ Health and Environmental Protection, Bilthoven, The Netherlands; C~Iealth and Welfare Canada, Ottawa, Canada; 7Freie Universit~t Berlin, Bedin-Dahlem, Germany; 8National Food Agency, S~aorg, Denmark; 9Texas A & M University, College Station TX, USA; l°Swiss Federal Institute of Toxicology, Schwerzenbach, Ziirich, Switzerland; 11WHOEuropean Centre for Environment and Health, Bilthoven, The Netherlands; 12Occupational Safety and Health Division, Tampere, Finland (Received in Germany 10 February 1994; accepted 16 February 1994) ABSTRACT The WHO-European Centre for Environment and Health (WHO-ECEH) and the International Programme on Chemical Safety (IPCS), have initiated a project to create a data base containing information relevant to the setting of Toxic Equivalency Factors (TEFs), and, based on the available information, to assess the relative potencies and to derive consensus TEFs for PCDDs, PCDFs and dioxin-like PCBs. Available data on the relative toxicities of dioxin-like PCBs with respect to a number of endpoints were collected and analyzed.
    [Show full text]
  • R Graphics Output
    Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 )
    [Show full text]
  • Chlorinated and Polycyclic Aromatic Hydrocarbons in Riverine and Estuarine Sediments from Pearl River Delta, China
    Environmental Pollution 117 (2002) 457–474 www.elsevier.com/locate/envpol Chlorinated and polycyclic aromatic hydrocarbons in riverine and estuarine sediments from Pearl River Delta, China Bi-Xian Maia,*, Jia-Mo Fua, Guo-Ying Shenga, Yue-Hui Kanga, Zheng Lina, Gan Zhanga, Yu-Shuan Mina, Eddy Y. Zengb aState Key Lab Laboratory of Organic Geochemistry, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, PO Box 1130, Guangzhou, Guangdong 510640, People’s Republic of China bSouthern California Coastal Water Research Project, 7171 Fenwick Lane, Westminster, CA 92683, USA Received 5 January 2001; accepted 3 July 2001 ‘‘Capsule’’: Sediments of the Zhujiang River and Macao Harbor have the potential to be detrimental to biological systems. Abstract Spatial distribution of chlorinated hydrocarbons [chlorinated pesticides (CPs) and polychlorinated biphenyls (PCBs)] and poly- cyclic aromatic hydrocarbons (PAHs) was measured in riverine and estuarine sediment samples from Pearl River Delta, China, collected in 1997. Concentrations of CPs of the riverine sediment samples range from 12 to 158 ng/g, dry weight, while those of PCBs range from 11 to 486 ng/g. The CPs concentrations of the estuarine sediment samples are in the range 6–1658 ng/g, while concentrations of PCBs are in the range 10–339 ng/g. Total PAH concentration ranges from 1168 to 21,329 ng/g in the riverine sediment samples, whereas the PAH concentration ranges from 323 to 14,812ng/g in the sediment samples of the Estuary. Sediment samples of the Zhujiang River and Macao harbor around the Estuary show the highest concentrations of CPs, PCBs, and PAHs. Possible factors affecting the distribution patterns are also discussed based on the usage history of the chemicals, hydrologic con- dition, and land erosion due to urbanization processes.
    [Show full text]
  • Frequent Occurrence of Gynandromorphs in the Natural Population of the Ant Vollenhovia Emeryi (Hymenoptera: Formicidae)
    Ins. Soc. 41:273-278 (1994) 1015-1621/94/030273-06 $1.50 + 0.20/0 1994 Birkh/iuser Verlag, Basel Frequent occurrence of gynandromorphs in the natural population of the ant Vollenhovia emeryi (Hymenoptera: Formicidae) K. Kinomura 1 and K. Yamauchi 2 1 Gifu-Aikawa High School, Gifu 501-31, Japan 2 Department of Biology, Faculty of Education, Gifu University, Gifu 501-11, Japan Key words: Vollenhovia emeryi; gynandromorph; dimorphism; microgyna; polygyny. Summary Many gynandromorphs were obtained from the natural population of Vollenhovia emeryi (mierogyna form) in Gifu, Japan. They were primarily male: most had the thorax and gaster of males, and the head contained tissues partially feminized to varying degrees. These gynandromorphs were found in 27 of 45 colonies studied (60.0%). Their proportion to total males in each colony varied from 3.7- 47.7 %, with a mean of 21.4 % (n = 21). The gynandromorphs were found in all study areas and in every study year, suggesting that gynandromorphism in this species is not a rare phenomenon. Moreover, this observation suggests that gynandromorphs may occur more frequently in micraners than in macraners. Introduction Gynandromorphs have been reported from 42 ant species in 22 genera (Jones and Phillips, 1985). There are many papers about gynandromorphism in ants but normally related to one or a few individuals among many species. The frequency of their occurrence in the natural population seems to be very low. In Japan, gynandromorphs have been recorded from Vollenhovia emeryi (Kubota, 1984), but the details remain unclear. Through our recent study on V. emeryi, we found extraordinarily frequent occurrences of gynandromorphs among the natural population.
    [Show full text]
  • Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium Fortunei
    International Journal of Molecular Sciences Article Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium fortunei Chun-Hao Chang 1, Semon Wu 2, Kai-Cheng Hsu 3,4, Wei-Jan Huang 5,6 and Jih-Jung Chen 7,8,9,* 1 Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan; [email protected] 2 Department of Life Science, Chinese Culture University, Taipei 110, Taiwan; [email protected] 3 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan; [email protected] 4 Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan 5 Ph.D. Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan; [email protected] 6 Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan 7 Department of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan 8 Faculty of Pharmacy, National Yang-Ming University, Taipei 112, Taiwan 9 Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2826-7195; Fax: +886-2-2823-2940 Abstract: Five new compounds, eupatodibenzofuran A (1), eupatodibenzofuran B (2), 6-acetyl-8- methoxy-2,2-dimethylchroman-4-one (3), eupatofortunone (4), and eupatodithiecine (5), have been isolated from the aerial part of Eupatorium fortunei, together with 11 known compounds (6-16).
    [Show full text]
  • Nuclear Receptors & Endocrine / Metabolic Disruption
    NUCLEAR RECEPTORS & ENDOCRINE / METABOLIC DISRUPTION Jack Vanden Heuvel, INDIGO Biosciences Inc., State College, PA Table of Contents Overview............................................................................................................ 3 a. Endocrine Disruption ........................................................................... 3 b Metabolic Disruption ............................................................................. 3 A Common Molecular Mechanism for Endocrine Disruption and Metabolic Disruption ...................... 4 Example endocrine and metabolic disruptors .................................. 5 a. Pesticides ................................................................................................... 6 b. “Dioxins” .................................................................................................... 7 c. Organotins ................................................................................................ 8 d. Polyfluoroalkyl compounds .............................................................. 9 e. Brominated flame retardants ............................................................ 10 f. Alkylphenols .............................................................................................. 11 g. Bisphenol A .............................................................................................. 12 h. Phthalates ................................................................................................. 13 Endocrine and metabolic disruption: Mechanistic
    [Show full text]
  • Examining Reproductive Health Outcomes in Females Exposed to Polychlorinated Biphenyl and Polybrominated Biphenyl Michael F
    www.nature.com/scientificreports OPEN Examining Reproductive Health Outcomes in Females Exposed to Polychlorinated Biphenyl and Polybrominated Biphenyl Michael F. Neblett II1*, Sarah W. Curtis2, Sabrina A. Gerkowicz1, Jessica B. Spencer1, Metrecia L. Terrell3, Victoria S. Jiang1, M. Elizabeth Marder4, Dana Boyd Barr4, Michele Marcus5 & Alicia K. Smith 6 In 1973, accidental contamination of Michigan livestock with polybrominated biphenyls (PBBs) led to the establishment of a registry of exposed individuals that have been followed for > 40 years. Besides being exposed to PBBs, this cohort has also been exposed to polychlorinated biphenyls (PCBs), a structurally similar class of environmental pollutants, at levels similar to average US exposure. In this study, we examined the association between current serum PCB and PBB levels and various female reproductive health outcomes to build upon previous work and inconsistencies. Participation in this cross-sectional study required a blood draw and completion of a detailed health questionnaire. Analysis included only female participants who had participated between 2012 and 2015 (N = 254). Multivariate linear and logistic regression models were used to identify associations between serum PCB and PBB levels with each gynecological and infertility outcome. Additionally, a generalized estimating equation (GEE) model was used to evaluate each pregnancy and birth outcome in order to account for multiple pregnancies per woman. We controlled for age, body mass index, and total lipid levels in all analyses. A p-value of <0.05 was used for statistical signifcance. Among the women who reported ever being pregnant, there was a signifcant negative association with higher total PCB levels associating with fewer lifetime pregnancies ( β = −0.11, 95% CI = −0.21 to −0.005, p = 0.04).
    [Show full text]
  • Polybrominated Biphenyls Bers of Bromine Atoms
    Report on Carcinogens, Fourteenth Edition For Table of Contents, see home page: http://ntp.niehs.nih.gov/go/roc Polybrominated Biphenyls bers of bromine atoms. PBBs are usually white, off‑white, or beige powders at room temperature (IPCS 1994). All of the congeners are Separate CAS Nos. are assigned to individual polybrominated insoluble in water but readily soluble in fat. PBBs are extremely sta‑ biphenyls ble and therefore persistent in the environment. Hexabromobiphe‑ Reasonably anticipated to be human carcinogens nyl (C12H4Br6, CAS No. 36355‑01‑8), one of 101 PBBs compounds in the CAS Registry system, is the main component of the com‑ First listed in the Third Annual Report on Carcinogens (1983) mercial PBB mixtures tested in animal carcinogenicity studies as Also known as PBBs FireMaster FF‑1 (FireMaster was registered as a trademark by the Michigan Chemical Corporation, St. Louis, MI). FireMaster FF‑1 was (Br) (Br)y x produced by grinding FireMaster BP‑6, the other main commercial hexabromo biphenyl PBB mixture (of which the major components were 4.0% pentabromobiphenyls, 62.6% hexabromobiphenyls, and Polybrominated biphenyls (number of bromine atoms [x + y] = 1–10) 33.4% heptabromo biphenyls) and blending it with 2% calcium poly‑ silicate as an anticaking agent (NTP 1993). Physical and chemical Carcinogenicity properties of hexabromobiphenyl, as a representative PBB, are listed in the following table. Polybrominated biphenyls (PBBs) are reasonably anticipated to be hu- man carcinogens based on sufficient evidence of carcinogenicity from Property Information studies in experimental animals. The animal studies used Fire Master Molecular weight 627.6 FF‑1, which is a commercial mixture of polybrominated biphenyl iso‑ Melting point 72°C mers, containing a mixture of pentabromobiphenyls, hexabromo‑ Log Kow 6.39 biphenyls, and heptabromobiphenyls.
    [Show full text]
  • Journal of Threatened Taxa
    PLATINUM The Journal of Threatened Taxa (JoTT) is dedicated to building evidence for conservaton globally by publishing peer-reviewed artcles OPEN ACCESS online every month at a reasonably rapid rate at www.threatenedtaxa.org. All artcles published in JoTT are registered under Creatve Commons Atributon 4.0 Internatonal License unless otherwise mentoned. JoTT allows unrestricted use, reproducton, and distributon of artcles in any medium by providing adequate credit to the author(s) and the source of publicaton. Journal of Threatened Taxa Building evidence for conservaton globally www.threatenedtaxa.org ISSN 0974-7907 (Online) | ISSN 0974-7893 (Print) Note A record of gynandromorphism in the libellulid dragonfly Crocothemis servilia (Insecta: Odonata) from India R.V. Renjith & A. Vivek Chandran 26 June 2020 | Vol. 12 | No. 9 | Pages: 16183–16186 DOI: 10.11609/jot.5322.12.9.16183-16186 For Focus, Scope, Aims, Policies, and Guidelines visit htps://threatenedtaxa.org/index.php/JoTT/about/editorialPolicies#custom-0 For Artcle Submission Guidelines, visit htps://threatenedtaxa.org/index.php/JoTT/about/submissions#onlineSubmissions For Policies against Scientfc Misconduct, visit htps://threatenedtaxa.org/index.php/JoTT/about/editorialPolicies#custom-2 For reprints, contact <[email protected]> The opinions expressed by the authors do not refect the views of the Journal of Threatened Taxa, Wildlife Informaton Liaison Development Society, Zoo Outreach Organizaton, or any of the partners. The journal, the publisher, the host, and the part-
    [Show full text]
  • Kinetic Study of Decomposition of Azo Dyes and Phenol in Advanced Oxidation Processes: Reaction Mechanisms, Pathways and Intermediates
    Copyright Warning & Restrictions The copyright law of the United States (Title 17, United States Code) governs the making of photocopies or other reproductions of copyrighted material. Under certain conditions specified in the law, libraries and archives are authorized to furnish a photocopy or other reproduction. One of these specified conditions is that the photocopy or reproduction is not to be “used for any purpose other than private study, scholarship, or research.” If a, user makes a request for, or later uses, a photocopy or reproduction for purposes in excess of “fair use” that user may be liable for copyright infringement, This institution reserves the right to refuse to accept a copying order if, in its judgment, fulfillment of the order would involve violation of copyright law. Please Note: The author retains the copyright while the New Jersey Institute of Technology reserves the right to distribute this thesis or dissertation Printing note: If you do not wish to print this page, then select “Pages from: first page # to: last page #” on the print dialog screen The Van Houten library has removed some of the personal information and all signatures from the approval page and biographical sketches of theses and dissertations in order to protect the identity of NJIT graduates and faculty. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted.
    [Show full text]
  • Guidance on Information Requirements and Chemical Safety Assessment Chapter R.6: Qsars and Grouping of Chemicals
    Guidance on information requirements and chemical safety assessment Chapter R.6: QSARs and grouping of chemicals May 2008 Guidance for the implementation of REACH LEGAL NOTICE This document contains guidance on REACH explaining the REACH obligations and how to fulfil them. However, users are reminded that the text of the REACH regulation is the only authentic legal reference and that the information in this document does not constitute legal advice. The European Chemicals Agency does not accept any liability with regard to the contents of this document. © European Chemicals Agency, 2008 Reproduction is authorised provided the source is acknowledged. 2 CHAPTER R.6 – QSARS AND GROUPING OF CHEMICALS PREFACE This document describes the information requirements under REACH with regard to substance properties, exposure, use and risk management measures, and the chemical safety assessment. It is part of a series of guidance documents that are aimed to help all stakeholders with their preparation for fulfilling their obligations under the REACH regulation. These documents cover detailed guidance for a range of essential REACH processes as well as for some specific scientific and/or technical methods that industry or authorities need to make use of under REACH. The guidance documents were drafted and discussed within the REACH Implementation Projects (RIPs) led by the European Commission services, involving stakeholders from Member States, industry and non-governmental organisations. These guidance documents can be obtained via the website of
    [Show full text]